about
Epidemiology and risk profile of heart failureUnderstanding the epidemic of heart failure: past, present, and futureHeart failure with preserved ejection fractionClinical Phenotypes in Heart Failure With Preserved Ejection FractionDiastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fractionUnderstanding heart failure; explaining telehealth - a hermeneutic systematic review.Role of RyR2 phosphorylation in heart failure and arrhythmias: protein kinase A-mediated hyperphosphorylation of the ryanodine receptor at serine 2808 does not alter cardiac contractility or cause heart failure and arrhythmiasCell-based therapy for heart disease: a clinically oriented perspectiveRed blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus.The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.Ten-year prognosis of heart failure in the community: follow-up data from the Echocardiographic Heart of England Screening (ECHOES) study.Epidemiology and clinical course of heart failure with preserved ejection fractionRight ventricular function in heart failure with preserved ejection fraction: a community-based studyMultimorbidity in heart failure: a community perspective.Understanding results of trials in heart failure with preserved ejection fraction: remembering forgotten lessons and enduring principlesThe impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction.Venous thromboembolism in patients with reduced estimated GFR: a population-based perspectiveHeart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma.A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunctionCardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.The challenge of heart failure discharge from the emergency department.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.Predictive value of beat-to-beat QT variability index across the continuum of left ventricular dysfunction: competing risks of noncardiac or cardiovascular death and sudden or nonsudden cardiac deathImpact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective.Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure.Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community.Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trialHeart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) studyContemporary strategies in the diagnosis and management of heart failureRole of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureMultimorbidity in Heart Failure: Effect on Outcomes.Patients with heart failure have an increased risk of incident cancer.Who has advanced heart failure?: definition and epidemiology.The emerging epidemic of heart failure with preserved ejection fraction.Mortality in heart failure patients.Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.Heart failure with preserved ejection fraction in the elderly: scope of the problem.
P2860
Q24630778-8A9B62DF-9A57-4838-AD73-8589B13C31A5Q26996486-0C27410E-FE06-4428-8C26-BFE08E0A9CB2Q27024008-CF92C7EB-D5F4-4554-A4E3-1123F744F003Q28073079-5FE07BB0-DA10-4A59-98E0-89E035EF60F1Q30530714-CD9DF587-B7C2-4482-AAD1-E1F91C6E42FEQ30855803-80896DC2-EE45-4EC6-9E1E-9CB009B4F306Q33693920-FB7DA123-6525-4373-80F6-0761197007D0Q33713519-5D95B2F7-05C8-4FCE-9580-BF5E2A20CE6CQ33883706-A5584E0A-3E75-49AB-927C-152E89D58A0EQ33984662-F69205DB-F20C-43BC-8342-E08A36423CEDQ34130091-9C2ABE10-3253-4999-8DB2-B1F1A8D505BCQ34413027-FD6E1A08-3988-427A-BBA0-DDF4A734F54EQ34772384-4D13A06C-F36A-427B-B07A-2E94CEAAA111Q34808976-BD144DDC-FC22-43D4-BD65-904EEC28C8D1Q34999474-76560FBE-F613-4B99-8263-C8792FA796FCQ35072339-6F1CE8B8-A00F-467A-8E06-46CFDA1398ABQ35479128-296AE6E4-008A-4509-83C2-82981750F731Q35536451-B8266981-7A06-459D-AC4C-4E352B896F03Q35627561-1D071C81-20D2-495B-90A9-B4E107BEB6B4Q35671472-47DE23DF-522C-4B94-9EF6-2DE9A3A68177Q35672064-6E5C2751-BEFA-4157-ADA2-D4B92C3ECF6EQ36120865-B30ABB62-2725-44B1-AD95-FCFDD92F92A8Q36167458-1EAA4397-6EFC-4333-90C8-E3865D6D4165Q36203696-9CC117C1-C595-4057-9A83-89A64BB7C7BFQ36393927-9D048D9A-096F-48A7-90C5-C7A520F99661Q36407129-AA611D22-7EA3-4AD2-BB36-9A02C39DFB4AQ36429019-A9A36C9E-EF06-4FCB-ABFB-A131713B0A4CQ36441592-EFB5D77A-3B01-4DC5-AA3D-32695132E98BQ36489384-FE0F7375-3B4A-4A60-A328-397718C047AFQ36623186-CE3EB788-BA78-479C-B4FF-35D386D52EB2Q36833984-076239FF-EB86-4D5D-9A84-6501415CC95BQ37041145-56509BA5-0A7C-46EA-93F7-A8B2E1FC1FA0Q37081415-A6104A61-5E26-45C8-8BA6-3A9A9C7BA664Q37092081-D0932025-2854-4596-BBAC-4CFCE16CF5BDQ37136235-7A8EACB5-CB35-4E92-BC2D-DF070A2334C9Q37379777-418E097C-80D9-40E2-B435-0D1E1D8FE99AQ37407880-09151263-AE51-4DC5-BCC1-E467FCFD4318Q37680497-051FF4C1-3207-405E-86FC-D9442378DA0FQ37725106-F0021F5F-FE23-4151-AB40-F07CB210CAF1Q37912065-AD58F429-5094-4D92-B2AF-30141AC1BA2D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Death in heart failure: a community perspective
@en
Death in heart failure: a community perspective.
@nl
type
label
Death in heart failure: a community perspective
@en
Death in heart failure: a community perspective.
@nl
prefLabel
Death in heart failure: a community perspective
@en
Death in heart failure: a community perspective.
@nl
P2093
P2860
P1476
Death in heart failure: a community perspective
@en
P2093
Danielle M Henkel
Margaret M Redfield
Susan A Weston
Véronique L Roger
Yariv Gerber
P2860
P356
10.1161/CIRCHEARTFAILURE.107.743146
P577
2008-07-01T00:00:00Z